Archer Baseline Assessment Practice Test 2026 - Free Practice Questions and Study Guide

A therapeutic response to bupropion is indicated primarily by a decrease in depressive symptoms. This decrease suggests that the medication is effectively addressing the underlying issues associated with depression. Bupropion is an antidepressant that primarily works by affecting neurotransmitters in the brain, specifically norepinephrine and dopamine, which are linked to mood regulation.

When a patient experiences a reduction in depressive symptoms, it reflects the medication's role in helping to improve mood, alleviate feelings of sadness, and enhance overall psychological well-being. Hence, monitoring for decreased symptoms is vital in assessing how well the treatment is working.

While improved sleep patterns and increased energy levels can also be part of a positive therapeutic response, they are not direct indicators of a decrease in depressive symptoms, which is the most critical measure of bupropion's effectiveness in treating depression. Increased depressive symptoms, on the other hand, would typically suggest that the medication is not working as intended.